Amgen (AMGN)
337.54
+1.47 (0.44%)
NASDAQ · Last Trade: Nov 22nd, 1:53 AM EST
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.
Via Benzinga · November 20, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via Chartmill · November 20, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.
Via StockStory · November 18, 2025
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.
Via Benzinga · November 18, 2025
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · November 17, 2025
Healthcare stocks have far outperformed the broader market over the past month.
Via The Motley Fool · November 17, 2025
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.
Via The Motley Fool · November 16, 2025
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an uncertain economic landscape. While specific real-time data for this future date is beyond current predictive capabilities, an analysis of the sector's
Via MarketMinute · November 14, 2025
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Via Benzinga · November 14, 2025
The pharmaceutical sector mainstay earned several positive mentions in the pundit sphere that day.
Via The Motley Fool · November 13, 2025
As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance, particularly by companies at the forefront of artificial intelligence (AI), tech stocks are now experiencing a noticeable downturn. This
Via MarketMinute · November 13, 2025
Innovative drugmakers often make for solid dividend stocks. These two companies are great examples.
Via The Motley Fool · November 13, 2025
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.
Via The Motley Fool · November 13, 2025
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by growing concerns over stretched valuations in the artificial intelligence (AI) sector and a pronounced rotation of capital into more traditional industries, marks a
Via MarketMinute · November 12, 2025
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the venerable index. This historic surge, following another record close yesterday, injects a palpable sense of optimism into the
Via MarketMinute · November 12, 2025
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones Industrial Average (DJIA) has simultaneously surged past the 48,000-point mark. As of November 12, 2025, gold prices are trading around $4,105-$4,
Via MarketMinute · November 12, 2025
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an unprecedented 48,015.79. This historic equity rally is unfolding concurrently with a robust ascent in precious metals,
Via MarketMinute · November 12, 2025
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was fueled by a wave of optimism surrounding the imminent resolution of a protracted U.S. government shutdown, which
Via MarketMinute · November 12, 2025
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points (1.2%). This marks the 16th record close for the index this year, sending a
Via MarketMinute · November 11, 2025
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely optimistic, sentiment across the financial markets. This monumental achievement signals a robust, albeit cautious, wave of investor confidence, underpinned by
Via MarketMinute · November 11, 2025
The company continued to bask in the glow of a very solid third quarter.
Via The Motley Fool · November 11, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
Via StockStory · November 11, 2025
These three healthcare stocks are outperforming most of the sector.
Via The Motley Fool · November 11, 2025